Related Experiment Videos
Subjects with obstructive pulmonary disease tend to be chronically vasodilated
E Casiglia1, L Pavan, L Marcato
1Department of Clinical and Experimental Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.
Clinical Science (London, England : 1979)
|September 9, 1998
Summary
Chronic obstructive pulmonary disease patients exhibit chronic vasodilatation linked to hypoxia, not PaCO2. The Borg index effectively indicates oxygen desaturation and vasodilatation in COPD.
Area of Science:
- Pulmonary Medicine
- Cardiovascular Physiology
Background:
- Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation and systemic effects.
- Understanding the relationship between respiratory function and cardiovascular parameters is crucial for managing COPD patients.
Purpose of the Study:
- To investigate arterial blood gases, respiratory function, and hemodynamic parameters in COPD patients.
- To explore the correlation between disease severity, dyspnea indices, and arterial flow.
- To determine the role of hypoxia and PaCO2 in vasodilatation in COPD.
Main Methods:
- Measurements included arterial pH, PaO2, PaCO2, SaO2, FEV1.0, vital capacity, and Borg index in 12 COPD outpatients and 6 controls.
- Calf arterial flow was assessed at rest and during reactive hyperemia using plethysmography.
- Subjects were categorized by obstruction severity using the Tiffenau index.
Main Results:
- Patients with obstruction had lower FEV1.0 and higher arterial flow compared to controls.
- Arterial flow increased progressively with COPD severity.
- Multiple regression analysis showed inverse correlation between arterial flow and FEV1.0, PaO2, SaO2, and direct correlation with PaCO2.
Conclusions:
- COPD patients tend to exhibit chronic vasodilatation primarily driven by hypoxia, with other mechanisms potentially involved.
- The Borg index serves as a reliable indicator of oxygen desaturation and vasodilatation in COPD.
- These findings highlight the complex interplay between respiratory impairment and cardiovascular changes in COPD.